AU2002331362A1 - New alkynylated quinazolin compounds as mmp-13 inhibitors - Google Patents

New alkynylated quinazolin compounds as mmp-13 inhibitors

Info

Publication number
AU2002331362A1
AU2002331362A1 AU2002331362A AU2002331362A AU2002331362A1 AU 2002331362 A1 AU2002331362 A1 AU 2002331362A1 AU 2002331362 A AU2002331362 A AU 2002331362A AU 2002331362 A AU2002331362 A AU 2002331362A AU 2002331362 A1 AU2002331362 A1 AU 2002331362A1
Authority
AU
Australia
Prior art keywords
alkynylated
mmp
inhibitors
new
quinazolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002331362A
Inventor
Bernard Gaudilliere
Henry Jacobelli
Joseph Armand Picard
Michael William Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU2002331362A1 publication Critical patent/AU2002331362A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002331362A 2002-07-12 2002-07-12 New alkynylated quinazolin compounds as mmp-13 inhibitors Abandoned AU2002331362A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2002/008475 WO2004007469A1 (en) 2002-07-12 2002-07-12 New alkynylated quinazolin compounds as mmp-13 inhibitors

Publications (1)

Publication Number Publication Date
AU2002331362A1 true AU2002331362A1 (en) 2004-02-02

Family

ID=30011048

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002331362A Abandoned AU2002331362A1 (en) 2002-07-12 2002-07-12 New alkynylated quinazolin compounds as mmp-13 inhibitors

Country Status (2)

Country Link
AU (1) AU2002331362A1 (en)
WO (1) WO2004007469A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090115953A (en) * 2007-03-06 2009-11-10 노파르티스 아게 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
TW201623257A (en) 2014-05-09 2016-07-01 奧利安公司 Pharmacologically active quinazolinedione derivatives
WO2016159746A1 (en) * 2015-03-27 2016-10-06 Latvian Institute Of Organic Synthesis Novel ethynylxanthines, their preparation and use as inhibitors of matrix metalloproteinases and angiogenesis
CN105085495B (en) * 2015-09-16 2019-01-04 湖南大学 The preparation method of N- alkynyl benzimidizole derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
DE4341665A1 (en) * 1993-12-07 1995-06-08 Basf Ag Bicyclic derivatives, their production and use
JPH10195063A (en) * 1996-10-21 1998-07-28 Dai Ichi Seiyaku Co Ltd Ethynylthiazole derivative
JP2002513394A (en) * 1996-12-17 2002-05-08 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー Fungicidal quinazolinones
US6425529B1 (en) * 1999-08-25 2002-07-30 Frank G. Reinsch Controlled injection of dry material into a liquid system
PA8539301A1 (en) * 2001-02-14 2002-09-30 Warner Lambert Co INHIBITORS OF THE METALOPROTEINASE OF THE MATRIX

Also Published As

Publication number Publication date
WO2004007469A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2003209077A1 (en) Pyrimidine compounds
AU2003266949A1 (en) Compounds
AU2003257094A1 (en) Substituted benzimidazole compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003301302A1 (en) Pyradazine compounds as gsk-3 inhibitors
AU2003265349A1 (en) Pyrrolotriazine kinase inhibitors
GB0229015D0 (en) New Compound
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003258045A1 (en) Novel gamma-lactams as beta-secretase inhibitors
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2003279366A1 (en) Novel compounds
AU2003287979A1 (en) Phenyl compounds
AU2003211385A1 (en) Azole compounds
AU2003216053A1 (en) Guanidino compounds
AU2003208467A1 (en) Pyrimidine compounds
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
WO2004100960A8 (en) Anti-inflammatory phosphonate compounds
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003224032A1 (en) Herbicidal composition comprising phenylpropynyloxypyridine compounds
AU2003250858A1 (en) Use of organic compounds
AU2003222206A1 (en) Novel benzimidazole compounds
AU2003282510A1 (en) Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
AU2003235122A1 (en) Cell death inhibitor
AU2002331362A1 (en) New alkynylated quinazolin compounds as mmp-13 inhibitors
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase